data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHZpZXdCb3g9IjAgODUuMzMzIDUxMiAzNDEuMzMzIj48cGF0aCBmaWxsPSIjRkZEQTQ0IiBkPSJNMCA4NS4zMzFoNTEydjM0MS4zMzdIMHoiLz48cGF0aCBkPSJNMCA4NS4zMzFoNTEydjExMy43NzVIMHptMCAyMjcuNTUxaDUxMnYxMTMuNzc1SDB6IiBmaWxsPSIjRDgwMDI3Ii8+PC9zdmc+Español
data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHZpZXdCb3g9IjAgODUuMzMzIDUxMiAzNDEuMzMzIj48cGF0aCBmaWxsPSIjRkZGIiBkPSJNMzQxLjMzNCA4NS4zM0gwdjM0MS4zMzJoNTEyVjg1LjMzeiIvPjxwYXRoIGZpbGw9IiM2REE1NDQiIGQ9Ik0wIDg1LjMzM2gxNzAuNjYzVjQyNi42N0gweiIvPjxwYXRoIGZpbGw9IiNEODAwMjciIGQ9Ik0zNDEuMzM3IDg1LjMzM0g1MTJWNDI2LjY3SDM0MS4zMzd6Ii8+PC9zdmc+Italiano
data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHZpZXdCb3g9IjAgODUuMzMzIDUxMiAzNDEuMzMzIj48cGF0aCBmaWxsPSIjRkZGIiBkPSJNMCA4NS4zMzFoNTEydjM0MS4zMzdIMHoiLz48cGF0aCBmaWxsPSIjMDA1MkI0IiBkPSJNMCA4NS4zMzFoMTcwLjY2M3YzNDEuMzM3SDB6Ii8+PHBhdGggZmlsbD0iI0Q4MDAyNyIgZD0iTTM0MS4zMzcgODUuMzMxSDUxMnYzNDEuMzM3SDM0MS4zMzd6Ii8+PC9zdmc+Français
SPY
––%
QQQ
––%
BTC/USD
––%
DIA
––%
GLD
––%
TLT
––%
Novo Nordisk
(NYSE:NVO)
$126.125
-0.005
At close: Dec 1(Delayed 15-Minutes)
Get Real Time Here
$126.0046
-0.1204[-0.10%]
PreMarket: 5:18PM EDT
Day Range- - -52 Wk Range91.51 - 126.41Open / Close- / -Float / Outstanding1.7B / 2.3B
Vol / Avg.- / 1.3MMkt Cap284BP/E38.8350d Avg. Price108.95
Div / Yield1.6/1.27%Payout Ratio47.89Total Float1.7BEPS6.37

Novo Nordisk Stock (NYSE:NVO), Quotes and News Summary

Novo Nordisk Stock (NYSE: NVO) stock price, news, charts, stock research, profile.

Day Range- - -52 Wk Range91.51 - 126.41Open / Close- / -Float / Outstanding1.7B / 2.3B
Vol / Avg.- / 1.3MMkt Cap284BP/E38.8350d Avg. Price108.95
Div / Yield1.6/1.27%Payout Ratio47.89Total Float1.7BEPS6.37
David Willey -
Vandana Singh - Nov 22, 2022, 9:48AM
Robert Kuczmarski - Nov 20, 2022, 8:48AM
Henry Khederian - Nov 2, 2022, 1:26PM
Vandana Singh - Nov 2, 2022, 8:41AM
Vandana Singh - Oct 12, 2022, 11:47AM
Vandana Singh - Oct 3, 2022, 1:53PM
Vandana Singh - Sep 29, 2022, 12:49PM
News Direct - Nov 21, 2022, 8:00AM
PRNewswire - Nov 2, 2022, 9:31AM
Business Wire - Sep 27, 2022, 11:42AM
AB Digital, Inc. - Sep 6, 2022, 11:20AM
Business Wire - Sep 2, 2022, 3:46PM
PRNewswire - Sep 1, 2022, 4:57PM
News Direct - Sep 1, 2022, 9:00AM
PRNewswire - Aug 22, 2022, 9:31AM
News Direct - Aug 18, 2022, 7:01PM
PRNewswire - Aug 4, 2022, 9:39AM
PRNewswire - Jul 26, 2022, 11:00AM
PRNewswire - Jun 23, 2022, 8:00AM
PRNewswire - Jun 14, 2022, 11:00AM
PRNewswire - May 31, 2022, 8:00AM
PRNewswire - May 11, 2022, 8:00AM
PRNewswire - Dec 14, 2021, 5:55PM
Seeking Alpha - 16 hours ago
StockNews - 18 hours ago
Seeking Alpha - 1 day ago
InvestorsObserver - 1 day ago
Seeking Alpha - 1 day ago
Seeking Alpha - 2 days ago
InvestorsObserver - 2 days ago
StockNews - 2 days ago
InvestorsObserver - 3 days ago
StockNews - 3 days ago
InvestorsObserver - 6 days ago
InvestorsObserver - Nov 23, 2022, 7:52AM
StockNews - Nov 23, 2022, 2:56AM
Seeking Alpha - Nov 22, 2022, 5:01AM
Seeking Alpha - Nov 19, 2022, 4:00PM
Seeking Alpha - Nov 17, 2022, 11:34AM
StockNews - Nov 15, 2022, 4:49AM
InvestorsObserver - Nov 14, 2022, 12:01PM
StockNews - Nov 14, 2022, 10:07AM
Seeking Alpha - Nov 12, 2022, 8:17PM
Seeking Alpha - Nov 12, 2022, 4:00PM
InvestorsObserver - Nov 11, 2022, 8:50AM
StockNews - Nov 11, 2022, 2:26AM
StockNews - Nov 10, 2022, 9:51AM
InvestorsObserver - Nov 7, 2022, 9:07AM
Seeking Alpha - Nov 5, 2022, 4:00PM
InvestorsObserver - Nov 4, 2022, 11:05AM
StockNews - Nov 4, 2022, 9:00AM
Seeking Alpha - Nov 4, 2022, 2:57AM
Seeking Alpha - Nov 3, 2022, 2:13PM
InvestorsObserver - Nov 3, 2022, 7:40AM
InvestorsObserver - Nov 2, 2022, 11:11AM
Seeking Alpha - Nov 2, 2022, 7:22AM
Sector: Health Care.Industry: Pharmaceuticals
With almost 50% market share by volume of the global insulin market, Novo Nordisk is the leading provider of diabetes-care products in the world. Based in Denmark, the company manufactures and markets a variety of human and modern insulins, injectable diabetes treatments, and oral antidiabetic agents. Novo also has a biopharmaceutical segment (constituting roughly 15% of revenue) that specializes in protein therapies for hemophilia and other disorders.
Read More

Earnings

see more
Q4 2022Est.ActualSurprise
EPS
(EXPECTED)2023-02-01
REV
Q3 2022Est.ActualSurprise
EPS0.8300.860 0.0300
REV5.890B6.174B284.000M

Analyst Ratings

see more
DateAnalyst FirmAnalyst NameActionRatingAction Price Prior Price Target
Q

How do I buy Novo Nordisk (NVO) stock?

A

You can purchase shares of Novo Nordisk (NYSE: NVO) through any online brokerage.

View our list of the best stock brokerages.

Q

Who are Novo Nordisk's (NVO) competitors?

Q

What is the target price for Novo Nordisk (NVO) stock?

A

The latest price target for Novo Nordisk (NYSE: NVO) was reported by UBS on Tuesday, June 28, 2022. The analyst firm set a price target for 0.00 expecting NVO to fall to within 12 months (a possible -100.00% downside). 6 analyst firms have reported ratings in the last year.

Q

Current Stock Price for Novo Nordisk (NVO)?

A

The stock price for Novo Nordisk (NYSE: NVO) is $126.125 last updated December 1, 2022, 8:59 PM UTC.

Q

Does Novo Nordisk (NVO) pay a dividend?

A

A quarterly cash dividend of $2.50 per share of Class A Common Stock. The quarterly cash dividend was payable on April 2, 2012 to stockholders of record on March 22, 2012.

Q

When is Novo Nordisk (NYSE:NVO) reporting earnings?

A

Novo Nordisk’s Q4 earnings are confirmed for Wednesday, February 1, 2023.

Q

Is Novo Nordisk (NVO) going to split?

A

There is no upcoming split for Novo Nordisk.

Q

What sector and industry does Novo Nordisk (NVO) operate in?

A

Novo Nordisk is in the Health Care sector and Pharmaceuticals industry. They are listed on the NYSE.